Maverick Capital 13F, Q1 2024
Lee Ainslie · quarter ending 31 March 2024 · filed 15 May 2024 · SEC CIK 934639
Common stock only: shares the fund reported owning at the quarter end, valued as filed. The filing also lists 2 put and call lines, reported at the value of the underlying shares; they are not ownership and are not in these totals.
Largest positions, Q1 2024
The 25 largest of 403 positions. Weights are against the whole filed book. Changes are in shares held, against the Q4 2023 filing.
| Company | Ticker | Value | % of book | vs Q4 2023 |
|---|---|---|---|---|
| COUPANG INC | CPNG | $965.22M | 18.7% | -26% shares |
| AMAZON COM INC | AMZN | $224.99M | 4.4% | -13% shares |
| NVIDIA CORPORATION | NVDA | $190.43M | 3.7% | +6% shares |
| PHILIP MORRIS INTL INC | PM | $172.65M | 3.4% | +21% shares |
| JONES LANG LASALLE INC | JLL | $158.29M | 3.1% | +25% shares |
| NU HLDGS LTD | $143.79M | 2.8% | -16% shares | |
| VISA INC | V | $128.34M | 2.5% | -4% shares |
| SALESFORCE INC | CRM | $127.70M | 2.5% | +15% shares |
| SOUTHWEST GAS HLDGS INC | SWX | $126.38M | 2.5% | +48% shares |
| CAMDEN PPTY TR | CPT | $110.35M | 2.1% | +57% shares |
| SEAGATE TECHNOLOGY HLDNGS PL | $108.55M | 2.1% | +6% shares | |
| ROCKET PHARMACEUTICALS INC | RCKT | $104.75M | 2.0% | -4% shares |
| SPRINGWORKS THERAPEUTICS INC | $93.94M | 1.8% | -34% shares | |
| ELECTRONIC ARTS INC | EA | $93.24M | 1.8% | new |
| GFL ENVIRONMENTAL INC | GFL | $92.82M | 1.8% | new |
| DOORDASH INC | DASH | $92.76M | 1.8% | -28% shares |
| SCHWAB CHARLES CORP | SCHW | $92.09M | 1.8% | +31% shares |
| BAXTER INTL INC | BAX | $90.60M | 1.8% | -3% shares |
| MAPLEBEAR INC | CART | $88.37M | 1.7% | +101% shares |
| LPL FINL HLDGS INC | LPLA | $87.30M | 1.7% | -32% shares |
| UBER TECHNOLOGIES INC | UBER | $84.47M | 1.6% | -32% shares |
| MICROSOFT CORP | MSFT | $77.34M | 1.5% | -9% shares |
| META PLATFORMS INC | META | $74.14M | 1.4% | -51% shares |
| ASTERA LABS INC | ALAB | $73.95M | 1.4% | new |
| NATERA INC | NTRA | $73.05M | 1.4% | new |
What changed since Q4 2023
Against the Q4 2023 filing, Maverick Capital opened 225 new positions, added to 105, trimmed 68, left 5 unchanged and exited 166. Every position is compared, matched on its CUSIP; a change of 2% or less in shares counts as unchanged.
New positions
and 217 more
Exited
- IMMUNOGEN INCwas $73.92M
- WDAYwas $65.14M
- QRVOwas $57.63M
- CBREwas $51.87M
- RCIwas $42.34M
- CRH PLCwas $38.40M
- BABAwas $36.60M
- NWSAwas $34.47M
and 158 more
Other quarters
Source: SEC Form 13F-HR, accession 0000947871-24-000481, filed by MAVERICK CAPITAL LTD. Values are as filed and cover US-listed positions only; a 13F does not show short positions or holdings outside the US. A 13F may be filed up to 45 days after the quarter ends, so the fund may have traded since. Educational information, not financial advice.